Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib and nilotinib
|
|
- Austen Hodge
- 7 years ago
- Views:
Transcription
1 Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib and nilotinib Table from the following article: Haouala A, Widmer N, Duchosal MA, Montemurro M, Buclin T, Decosterd LA. Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. Blood Legend: The Table (in 17 parts) summarizes observed or potential drug interactions between TKIs and commonly concomitantly prescribed drugs or classical interacting agents (lines) sorted according to the ATC classification. The arrows and indicate an increase or decrease of drug concentration respectively. Boldface text outlines interactions reported in the literature (reference number), whereas standard characters represent potential interactions predicted from theoretical considerations (but not yet reported in the literature). Absence of interaction means that a clinical study concluded to the absence of interaction (reference number), and a box shaded in grey means that no interaction is either reported or theoretically expected Disclaimer: This table summarizes potential drug interactions between some commonly prescribed drugs (lines) and three tyrosine kinase inhibtors (columns). Each cell indicates the type of interaction expected when the drug is taken together with the corresponding tyrosine kinase inhibitor. The data presented are however only indicative and do not replace clinical judgment necessary when treating patients with multiple drugs. Not all interactions are expected to have clinical significance and/or to imply dosage adjustment. It is also of importance to check regularly for updated literature on this topic. References: See full article.
2 Alimentary tract and metabolism Omeprazole Inhibition of Pgp by omeprazole : dasatinib absorption PPI Esomeprazole Inhibition of Pgp by esomeprazole : dasatinib absorption Pantoprazole Inhibition of Pgp by pantoprazole: dasatinib absorption H2-antagonists Cimetidine Ranitidine Inhibition of CYP 3A4 and Pgp by cimetidine : Inhibition of hoct1 by cimetidine : Inhibition of Pgp by ranitidine : Inhibition of hoct1 by ranitidine : dasatinib absorption dasatinib absorption cimetidine : Antiemetics Metoclopramide Insulin Metformin Inhibition of hoct1 by metformin : Glibenclamide 2C9 by glibenclamide exposure Inhibition of Pgp by glibenclamide : glibenclamide exposure Inhibition of Pgp by glibenclamide : 2C9 by glibenclamide exposure Antidiabetic drugs Acarbose Rosiglitazone Pioglitazone rosiglitazone exposure 2C9 by pioglitazone exposure pioglitazone exposure rosiglitazone exposure 2C9 by pioglitazone exposure Nateglinide 2C9 by nateglinide exposure nateglinide exposure 2C9 by nateglinide exposure Repaglinide pioglitazone exposure 2C8 by pioglitazone exposure 2C8 by pioglitazone exposure 2
3 Blood and blood forming organs Antiplatelet drug a Clopidogrel 2C19 by clopidogrel exposure clopidogrel bioactivation clopidogrel exposure clopidogrel bioactivation Thrombocytopenic effect of risk of bleeding clopidogrel exposure clopidogrel bioactivation Acenocoumarol anticoagulation monitor PT/INR Thrombocytopenic effect of risk of bleeding anticoagulation monitor PT/INR Phenprocoumon anticoagulation monitor PT/INR Thrombocytopenic effect of risk of bleeding anticoagulation monitor PT/INR Warfarin anticoagulation monitor PT/INR Thrombocytopenic effect of risk of bleeding anticoagulation monitor PT/INR Anticoagulants a Heparin Inhibition of Pgp by heparin: Thrombocytopenic effect of risk of bleeding Inhibition of Pgp by heparin: Enoxaparin Thrombocytopenic effect of risk of bleeding Nadroparin Thrombocytopenic effect of risk of bleeding Dalteparin Thrombocytopenic effect of risk of bleeding 3
4 Cardiovascular system Calcium channel blockers Verapamil Diltiazem Nifedipine Amlodipine verapamil exposure verapamil: diltiazem exposure diltiazem: nifedipine exposure amlodipine exposure verapamil exposure verapamil: diltiazem exposure diltiazem: nifedipine exposure amlodipine exposure verapamil exposure verapamil: diltiazem exposure diltiazem: Inhibition of CYP3A4 by nifedipine exposure amlodipine exposure Molsidomine NO precursors Isosorbid mononitrate (ISMN) Isosorbid dinitrate (ISDN) ISMN exposure ISDN exposure ISMN exposure ISDN exposure ISMN exposure ISMN exposure Nitroglycerine HMG-CoA reductase inhibitors Simvastatin Pravastatin Atorvastatin Rosuvastatin simvastatin exposure Inhibition of Pgp by simvastatin: atorvastatin exposure Inhibition of Pgp by atorvastatin: simvastatin exposure Inhibition of Pgp by simvastatin: atorvastatin exposure Inhibition of Pgp by atorvastatin: Inhibition of CYP 3A4 by simvastatin exposure atorvastatin exposure Antiarrhythmic drugs Amiodarone Quinidine amiodarone exposure Inhibition of CYP3A4 and Pgp by amiodarone: Inhibition of hoct1 by amiodarone : quinidine exposure Inhibition of Pgp by quinidine: Inhibition of hoct1 by quinidine : amiodarone exposure amiodarone: quinidine exposure Inhibition of Pgp by quinidine: Inhibition of Pgp and CYP 3A4 by amiodarone exposure amiodarone: QT interval => monitor ECG quinidine exposure 4
5 Furosemide Absence of interaction Diuretics Torasemide Hydrochlorothiazide torasemide exposure torasemide exposure Spironolactone Inhibition of Pgp by spironolactone: Inhibition of Pgp by spironolactone: Metoprolol metoprolol exposure Inhibition of Pgp by metoprolol: metoprolol exposure Beta blockers Bisoprolol Carvedilol bisoprolol exposure Inhibition of CYP 2C9 and 2D6 by carvedilol exposure Inhibition of Pgp by carvedilol: bisoprolol exposure Inhibition of Pgp by carvedilol: bisoprolol exposure Inhibition of CYP 2C9 and 2D6 by carvedilol exposure Atenolol Absence of interaction Captopril captopril exposure Inhibition of Pgp by captopril: Inhibition of Pgp by captopril: captopril exposure ACE inhibitors Enalapril Ramipril enalapril exposure Inhibition of Pgp by enalapril: Inhibition of Pgp by enalapril: dasatinib exposure enalapril exposure Lisinopril Inhibition of Pgp by lisinopril exposure Inhibition of Pgp by lisinopril: Inhibition of Pgp by lisinopril: AT II receptor blockers Losartan Candesartan Inhibition of CYP 2C9 and 3A4 by losartan exposure and losartan bioactivation Inhibition of Pgp by losartan: losartan exposure Inhibition of Pgp by losartan: Inhibition of CYP 2C9 and 3A4 by losartan exposure and losartan bioactivation Cardiac glycosides Digoxin digoxin absorption (unknown mechanism) Inhibition of Pgp by digoxin exposure 5
6 Hormonal preparations Prednisone Corticosteroids Dexamethasone dexamethasone : dexamethasone : dexamethasone : Betamethasone Thyroid therapy Levothyroxine Induction of UGTs by imatinib : levothyroxine levothyroxine: levothyroxine: levothyroxine: Carbimazole Antineoplastic agents Cyclophosphamide Inhibition of CYP 2D6 and 3A4 by cyclophosphamide exposure cyclophosphamide bioactivation cyclophosphamide exposure cyclophosphamide bioactivation Induction of CYP 2B6 by cyclophosphamide exposure cyclophosphamide bioactivation Antiestrogen agent Tamoxifen Inhibition of CYP 2D6 and 3A4 by tamoxifen exposure tamoxifen bioactivation tamoxifen exposure tamoxifen bioactivation Inhibition of CYP 2D6 and 3A4 by tamoxifen exposure tamoxifen bioactivation 6
7 Anti-infectives Penicillins Amoxicillin Flucloxacillin Cephalosporins Céfuroxime Cefpodoxime Ceftriaxone Macrolides Clarithromycin Azithromycin Erythromycin Pgp by clarithromycin: Pgp by erythromycin: Pgp by clarithromycin: Pgp by erythromycin: Inhibition of CYP 3A4 by clarithromycin: Inhibition of CYP 3A4 by erythromycin: Tertracyclines Doxycyclin Ciprofloxacin Inhibition of Pgp by ciprofloxacin: Inhibition of Pgp by ciprofloxacin: Quinolones Levofloxacin Inhibition of Pgp by levofloxacin: Inhibition of hoct1 by levofloxacine : Inhibition of Pgp by levofloxacin: Norfloxacin Sulfonamides Co-trimoxazole co-trimoxazole Inhibition of CYP 2C9 by co-trimoxazole 7
8 Itraconazole Pgp by itraconazole: itraconazole: itraconazole: Azoles Fluconazole Voriconazole Pgp by fluconazole: voriconazole: fluconazole: voriconazole: fluconazole: voriconazole: Ketoconazole Pgp by ketoconazole: ketoconazole: ketoconazole: Allylamine Terbinafine 2C9 by terbinafine exposure terbinafine exposure 2C9 by terbinafine exposure Nitroimidazole Metronidazole Aciclovir Absence of interaction Antiviral/Nucleoside analog Valaciclovir Ganciclovir Valganciclovir Absence of interaction Inhibition of hoct1 by ganciclovir : imatinib intracellular exposure Inhibition of hoct1 by ganciclovir : imatinib intracellular exposure Antimycobacterials Rifampicine Isoniazide Ethambutol rifampicine: rifampicine: rifampicine: 8
9 Ritonavir ritonavir: ritonavir: Saquinavir saquinavir exposure Inhibition of hoct1 by saquinavir : saquinavir exposure saquinavir exposure Protease inhibitors Darunavir Atazanavir Tipranavir darunavir: atazanavir exposure tipranavir exposure tipranavir: darunavir: atazanavir exposure tipranavir exposure tipranavir: darunavir: atazanavir exposure tipranavir exposure tipranavir: Indinavir indinavir exposure Inhibition of hoct1 by indinavir : indinavir exposure indinavir exposure Nucleoside and nucleotide reverse transcriptase inhibitors Lamivudine Emtricitabine Zidovudine Inhibition of hoct1 by lamivudine : Non-nucleoside reverse transcriptase inhibitors Efavirenz Nevirapine Etravirine efavirenz exposure efavirenz: nevirapine exposure nevirapine: Inhibition of CYP 2C9 and 3A4 by etravirine exposure etravirine: efavirenz exposure efavirenz: nevirapine exposure nevirapine: etravirine exposure etravirine: efavirenz exposure efavirenz: nevirapine exposure nevirapine: Inhibition of CYP 2C9 and 3A4 by etravirine exposure etravirine: 9
10 Quinine quinidine exposure Inhibition of CYP 2D6 and Pgp by quinidine: Inhibition of hoct1 by quinine : quinidine exposure quinidine exposure quinidine exposure Chloroquine Inhibition of Pgp by chloroquine: Inhibition of hoct1 by chloroquine : Inhibition of Pgp by chloroquine: Antimalarial drugs Mefloquine mefloquine exposure Inhibition of Pgp by mefloquine: mefloquine exposure Inhibition of Pgp by mefloquine: Ppg by mefloquine exposure Proguanil Inhibition of CYP 2C19 and Pgp by proguanil exposure proguanil bioactivation Atovaquone Doxycycline 10
11 Immunomodulating agents Ciclosporin ciclosporin exposure Inhibition of Pgp and CYP 3A4 by ciclosporin: ciclosporin exposure Inhibition of CYP3A4 and Pgp by ciclosporin: Inhibition of CYP 3A4 and Pgp by ciclosporin exposure Inhibition of CYP3A4 by ciclosporin: Tacrolimus tacrolimus exposure Inhibition of Pgp by tacrolimus: tacrolimus exposure Inhibition of Pgp by tacrolimus: Pgp by tacrolimus exposure Immunosuppressants Sirolimus Everolimus sirolimus exposure everolimus exposure sirolimus exposure everolimus exposure Pgp by sirolimus exposure Pgp by everolimus exposure Mycophenolate mofetil Methotrexate Azathioprine 11
12 Musculo-skeletal system Aspirin Thrombocytopenic effect of risk of bleeding Ibuprofen ibuprofen exposure Inhibition of CYP 2C8 by ibuprofen exposure Inhibition of CYP 2C8 and 2C9 by ibuprofen exposure NSAIDs Mefenacid mefenacid exposure Inhibition of CYP 2C8 by mefenacid exposure Inhibition of CYP 2C8 and 2C9 by mefenacid exposure Metamizole metamizole: metamizole : metamizole : Diclofenac diclofenac exposure Inhibition of Pgp by diclofenac: Inhibition of CYP 2C8 by diclofenac exposure Inhibition of Pgp by diclofenac: Inhibition of CYP 2C8 and 2C9 and by diclofenac exposure Antigout preparations Allopurinol 12
13 Nervous system Fluoxetine fluoxetine exposure Fluvoxamine fluvoxamine exposure fluvoxamine exposure SSRI Paroxetine paroxetine exposure paroxetine exposure Citalopram 2D6 by citalopram exposure citalopram exposure 2D6 by citalopram exposure SSNRI Sertraline Venlafaxine 2D6 by sertraline exposure 2D6 by venlafaxine exposure sertraline exposure venlafaxine exposure 2D6 by sertraline exposure 2D6 by venlafaxine exposure Duloxetine duloxetine exposure duloxetine exposure Tetracyclic agent Mirtazapine 2D6 by mirtazapine exposure mirtazapine exposure 2D6 by nilotinib : mirtazapine exposure Tricyclic agents Trimipramine Amitriptyline trimipramine exposure 2D6 by amitriptyline exposure amitriptyline exposure trimipramine exposure 2D6 by amitriptyline exposure Phenothiazines Levomepromazine levomepromazine exposure levomepromazine exposure 13
14 Zolpidem zolpidem exposure zolpidem exposure zolpidem exposure Z-drugs Zaleplon zaleplon exposure zaleplon exposure zaleplon exposure Zopiclon zopiclon exposure zopiclon exposure zopiclon exposure Alprazolam alprazolam exposure alprazolam exposure alprazolam exposure Bromazepam bromazepam exposure bromazepam exposure bromazepam exposure Clonazepam clonazepam exposure clonazepam exposure clonazepam exposure Benzodiazepines Oxazepam Lorazepam Diazepam Midazolam diazepam exposure midazolam exposure Inhibition of Pgp by midazolam: Inhibition of hoct1 by midazolam : diazepam exposure midazolam exposure Inhibition of Pgp by midazolam: diazepam exposure midazolam exposure Barbiturates Phenobarbital Inhibition of CYP 2C9 and 2C19 by phenobarbital exposure phenobarbital: phenobarbital: phenobarbital exposure phenobarbital: 14
15 Antipsychotic agents Haloperidol Clozapine Olanzapine 2D6 by haloperidol exposure 2D6 by clozapine exposure haloperidol exposure clozapine exposure 2D6 by clozapine exposure Risperidone risperidone exposure Phenytoin phenytoin : phenytoin : phenytoin : Antiseizure drugs Valproic acid Carbamazepine Lamotrigine Inhibition of CYP 2C9 and 2C19 by valproic acid exposure valproic acid: Induction of CYP 3A4 and Pgp by carbamazepine: valproic acid : Induction of CYP 3A4 and Pgp by carbamazepine: valproic acid exposure valproic acid : carbamazepine: Gabapentin Topiramate topiramate : topiramate : topiramate : Levetiracetam Antimaniac drug Lithium Aminoketone Bupropion Induction of CYP 2B6 by bupropion exposure bupropion bioactivation 15
16 Morphine Tramadol 2D6 by imatinib : tramadol exposure tramadol bioactivation dasatinib : tramadol exposure 2D6 by nilotinib : tramadol exposure tramadol bioactivation Opioids Methadone imatinib : methadone exposure Inhibition of Pgp by methadone:. dasatinib : methadone exposure Inhibition of Pgp by methadone:. nilotinib : methadone exposure Induction of CYP 2B6 by methadone exposure Hydromorphone Oxycodone 2D6 by imatinib : oxycodone exposure oxycodone bioactivation dasatinib : oxycodone exposure 2D6 by nilotinib : oxycodone exposure oxycodone bioactivation Buprenorphine imatinib : buprenorphine exposure buprenorphine exposure buprenorphine exposure Other Acetaminophen Inhibition of o- glucuronidation by imatinib : acetaminophen exposure Antimigraine preparations Dihydroergotamine Sumatriptan dihydroergotamine exposure dihydroergotamine exposure dihydroergotamine exposure 16
17 Respiratory system Cetirizin Inhibition of Pgp by cetirizin exposure H1-antagonists Levocetirizin Loratadin imatinib : loratadin exposure loratadin exposure Inhibition of Pgp by cetirizin exposure Inhibition of Pgp by loratadin exposure Fexofenadin Anti asthma drugs Salbutamol Theophylline 17
18 Miscellaneous St John s wort St John s wort: St John s wort: St John s wort: Grapefruit Pgp by grapefruit: Pgp by grapefruit: grapefruit: Licorice licorice: licorice: licorice: a TKIs in general can cause thrombocytopenia, which is usually of no clinical relevance, please take that into consideration when coadministrating with anticoagulant medication. 18
PROJECT LIST GENERIC PRODUCTS
PROJECT LIST GENERIC PRODUCTS Acetylcysteine, Effervescent tablets 200 mg, 600 mg Alendronate sodium, Tablets 10, 70 mg Alfuzosin,Tablets 2.5mg Alfuzosin, ER Tablets 10 mg Ambroxol, Effervescent tablets
More information612 Program Midtown Express Pharmacy
ALENDRONATE SOD TAB 35MG (max 1 per week) $37.00 $70.00 ALENDRONATE SOD TAB 70MG (max 1 per week) $37.00 $70.00 ALLOPURINOL TAB 100MG $20.00 $38.00 ALLOPURINOL TAB 300MG $20.00 $38.00 AMITRIPTYLINE TAB
More informationClinically Significant Cardiovascular. Drug Interactions. April 30, 2014 Michael A Militello, PharmD, BCPS Cardiovascular Clinical Pharmacist
Clinically Significant Cardiovascular Drug Interactions April 30, 2014 Michael A Militello, PharmD, BCPS Cardiovascular Clinical Pharmacist Introduction Drug interactions represent 3-5% of preventable
More informationMeasuring Generic Efficiency in Part D
Measuring in Part D Rates among Medicare Part D Generic efficiency rate is a measurement of the total number of prescrip=ons filled as a generic for products with a direct generic subs=tute within a therapeu=c
More informationPalliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers
Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Important Notes: Last Updated: May 11, 2015 Pharmacists must submit a claim on PharmaNet at the time of purchase to enable coverage.
More informationDrug/Drug and Drug/Food Interactions with Target-Specific Oral Anticoagulants
Drug/Drug and Drug/Food Interactions with Target-Specific Oral Anticoagulants Sara R. Vazquez, PharmD, BCPS, CACP Clinical Pharmacist University of Utah Health Care Thrombosis Service Nothing to disclose
More informationEach un coated tablet contains: Nimesulide. Each un coated tablet contains: Nimesulide Paracetamol
Sr No. Generic Name Composition Claim 1 Tabs. 100/ 2 + Para Tabs. 3 + Tizanidine Tabs. 4 + Tabs. 5 +Serratio Tabs. 6 +Serratio Tabs. 7 Aceclo Tabs. IP 8 Aceclo + Para Tabs. 9 Aceclo + Para + Chlorzoxazone
More informationPREFERRED GENERIC DRUG LIST
These discount programs are NOT health insurance policies and are not intended as a substitute for insurance. The programs do not qualify as a minimum creditable coverage under Massachusetts law or where
More information$4, 30-day $10, 90-day
$4 Prescriptions - Choose from hundreds of generic drugs and over the counter medications. Free Home Delivery Mailed right to your home Free shipping Prescription Program includes up to a 30-day supply
More informationPerioperative Medication Management
CARDIOVASCULAR Beta blockers (metoprolol, atenolol, others) Should be continued until and including the day of Ace inhibitors (ACEI) & Angiotensin receptor blockers (ARB) (captopril, lisinopril, losartan,
More informationDirect antiviral therapy of hcv and relevant drug drug interactions for ivdu
Direct antiviral therapy of hcv and relevant interactions for ivdu Stefan Mauss Center for HIV and Hepatogastroenterology Duesseldorf, Germany Disclosures Advisory board: Abbvie, BMS, Boehringer Ingelheim,
More informationAnti Protozoal. Albendazole Oral Suspension USP Albendazole Tablets USP 400 mg Anti Malarial
ANTI-INFECTIVES Anti Biotics Levofloxacin Tablets 250, 500, 750 mg Ofloxacin Tablets 200, 400 mg Sparfloxacin Tablets 200 mg Ciprofloxacin Tablets USP 250, 500 mg Ofloxacin & Ornidazole Tablets Nitrofurantoin
More information$10.00 PRESCRIPTION PROGRAM DETAILS
$10.00 PRESCRIPTION PROGRAM DETAILS 1. The $10.00 program applies only to certain generic drugs at commonly prescribed 90 day usage dosages. (See list). 2. The Program may change without notification and
More informationCases in Drug Interactions with Anticoagulation Therapy Philip M. Hritcko, Pharm.D.,., CACP Assistant Dean for Experiential Education & Associate Clinical Professor University of Connecticut School of
More informationBC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients. Drug Benefit List. Updated February 15, 2016
BC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients Drug Benefit List Updated February 15, 2016 The FSDP will operate following rules established by the
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked
More informationManaging Drug Interactions in Transplant Recipients
Managing Drug Interactions in Transplant Recipients David J. Quan, Pharm.D., BCPS Clinical Pharmacist Clinical Professor of Pharmacy Department of Pharmaceutical Services UCSF Medical Center Goals and
More informationBreaking News. Dangerous Caring. The invisible pandemic. 1000 older adults 06/02/2015
Breaking News Dangerous Caring How good medicines can be bad for your health and how to avoid it Dee Mangin David Braley Nancy Gordon Chair in Family Medicine Prescribing in UTIs dangerous? Cotrimoxazole
More informationPerspective Hepatitis C Virus Direct-Acting Antiviral Drug Interactions and Use in Renal and Hepatic Impairment
Perspective Hepatitis C Virus Direct-Acting Antiviral Drug Interactions and Use in Renal and Hepatic Impairment Direct-acting antiviral (DAA) drugs exhibit considerable variability in mechanisms of metabolism
More informationDRUG FOOD INTERACTIONS
ANTIHYPERTENSIVES Natural licorice in large amounts can aggravate high blood pressure and can lower potassium levels. Natural licorice should be avoided with all antihypertensive medications. (Read food
More informationUnitedHealthcare Group Medicare Advantage (PPO)
Your Plan Explained UnitedHealthcare Group Medicare Advantage (PPO) UHEX11MP3230855_001 Y0066_100616_09113 Your Medicare. This brochure explains your Medicare Advantage plan, a type of health plan also
More informationThe 365-day period begins with the first dispensing transaction for each Ontario Drug Benefit (ODB) recipient on or after October 1, 2015.
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Chronic-use Medications List by In accordance with subsection 18 (11.1) of Ontario Regulation 201/96 made under the Ontario Drug Benefit
More informationDirectory of Generic Medications Eligible for Rx Savings Program Flat Fees
Directory of Generic Medications Eligible for Rx Savings Program Flat Fees CONNECTICUT VERSION If you re already enrolled in the FREE* Rx Savings Program, use this guide to find your best choices. And,
More informationTime to onset, remarks, outcome - tinnitus one day after start, outcome unknown. Adverse drug reaction
SSRIs and Introduction Selective serotonin re-uptake inhibitors (SSRIs) are antidepressants which have been approved for the Dutch market mainly for the treatment of depressive episodes. The group of SSRIs
More informationMembers enjoy more Pharmacy savings *
Sam s Plus Members enjoy more Pharmacy savings 5 prescription drugs available for FREE Generic medications: Donepezil, Pioglitazone, Escitalopram, Finasteride and Vitamin D2 50,000IU are $ 0 for a 30-day
More informationPharmacogenomics - Moving from the Paradigm of Typical to Individual in Your Practice. Bethany Reed, RN, MSN
Pharmacogenomics - Moving from the Paradigm of Typical to Individual in Your Practice Bethany Reed, RN, MSN 22nd Annual Northeast Regional Nurse Practitioner Conference May 6-8, 2015 DISCLOSURES There
More informationThe Novel Oral Anticoagulants
Induction and Follow up: The Novel Oral Anticoagulants Frances Akinwunmi, Consultant Pharmacist, Anticoagulation Imperial College Healthcare NHS Trust Overview Recap on context NICE guidance Key features
More informationDrug Classifications. Cholinergic (parasympathetic) drugs Ex. Acetylcholine, bethanecol, neostigmine, guanidine
Drug Classifications I. Autonomic nervous system drugs Cholinergic (parasympathetic) drugs Ex. Acetylcholine, bethanecol, neostigmine, guanidine Cholinergic blocking drugs Ex. Atropine, scopolamine Adrenergic
More informationClinically Significant Drug Interactions: When Not to Roll the Dice
Clinically Significant Drug Interactions: When Not to Roll the Dice Melissa Ranieri, PharmD Clinical Associate Professor Temple University School of Pharmacy Disclosures I have no relevant financial relationships
More informationSAVE ON MEDICAL SERVICES and PRESCRIPTION DRUGS for ongoing conditions
SAVE ON MEDICAL SERVICES and PRESCRIPTION DRUGS for ongoing conditions With Dickinson College s Value Based Insurance Design (VBID) If you have an ongoing condition, you can live well. You will need to
More informationRetail Prescription Program Drug List
Retail Prescription Program Drug List Price Matters New Men s Health Category Convenience Free Home Delivery Our 4 prescriptions have saved our customers over 3 billion The program is available to everyone,
More informationGeneric Pharmacy Discount
Generic Pharmacy Discount 83 Park Place Blvd Suite 101 Clearwater, FL 33759 Fourth Quarter 2014 727.461.6044 800.314.0088 Pharmacies Generic Discount Program Information Enclosed information provided
More informationHome Delivery Prescription Program Drug List
Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think
More informationSummary of some common drug interactions seen in Aged Care Homes
Summary of some common drug interactions seen in Aged Care Homes Jenny Gowan Consultant pharmacist NEVDGP February 2011 1 Potassium supplements & potassium-sparing drugs eg Potassium chloride plus K sparing
More informationSlide 1. Slide 2. Slide 3. Disclosures. Objectives DRUG INTERACTIONS WITH NEW ORAL ANTICOAGULANTS. None
Slide 1 DRUG INTERACTIONS WITH NEW ORAL ANTICOAGULANTS Michelle Friedman, B.S., Pharm.D. PGY-2 Internal Medicine Pharmacy Resident Kingsbrook Jewish Medical Center Chanie Wassner, Pharm.D. PGY-2 Critical
More informationEmit Drugs of Abuse Urine Assays Cross-Reactivity List. Answers for life.
Emit Drugs of Abuse Urine Assays Cross-Reactivity List Answers for life. Contents Emit II Plus Amphetamines...4 Emit II Plus Barbiturate...8 Emit II Plus Benzodiazepine... 12 Emit II Plus Cannabinoid...
More informationDrug-Drug Interactions in the Treatment of Hepatitis C
Drug-Drug Interactions in the Treatment of Hepatitis C Jennifer J. Kiser, PharmD University of Colorado Denver Department of Pharmaceutical Sciences May 11, 2013 Disclosures Jennifer Kiser receives or
More informationNEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES :
LOCOST 85, GIDC Estate, Por-Ramangamdi, N.H.8, Dist. Vadodara - 391 243 Gujarat, India. Tel. No.: (91-265) 2830009 Fax No.: (P.P.) 2831446 E-mail: locost@sify.com Website: www.locostindia.com A Public
More informationANTICOAGULANT DRUG INTERACTIONS. New Agents, New Concerns
ANTICOAGULANT DRUG INTERACTIONS New Agents, New Concerns Ann K Wittkowsky PharmD, CACP, FASHP, FCCP Clinical Professor University of Washington School of Pharmacy Director, Anticoagulation Services UWMedicine
More informationOs Novos Anticoagulantes não são necessários
Os Novos Anticoagulantes não são necessários H. Luz Rodrigues Serviço de Nefrologia e Transplantação Instituto de Farmacologia e Neurociências 1948 Introdução dum ratícida Warfarin Wisconsin Alumni Research
More informationDrugs & driving: the place of medication reviews in improving safety for older road users. Dr Jenny Gowan
Drugs & driving: the place of medication reviews in improving safety for older road users Dr Jenny Gowan Consultant pharmacist, Northern & North East Valley Divisions of General Practice, Melbourne, Victoria,
More informationPackage leaflet: Information for the user. Norvir 100 mg film-coated tablets ritonavir
Package leaflet: Information for the user Norvir 100 mg film-coated tablets ritonavir Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPatient Information Leaflet Drug interaction with ED drug treatments
Patient Information Leaflet Drug interaction with ED drug treatments This document is intended for information purposes only and should be used in conjunction with the advice and further details to be
More informationThe Grand Master vs. New Kids on the Block
Hong Kong Pharmacy Conference 2013: Therapeutic Debate - Session 1 The Grand Master vs. New Kids on the Block Should warfarin or new oral anticoagulants (NOACs) claim the throne as 1st line agent for stroke
More informationCHAPTER 2B HIV DRUG-DRUG INTERACTIONS I. INTRODUCTION GENERAL RECOMMENDATIONS:
CHAPTER 2B HIV DRUG-DRUG INTERACTIONS I. INTRODUCTION II. GENERAL RECOMMENDATIONS: The practitioner should conduct a thorough medication history at each visit that includes prescription medications, over-the-counter
More informationPREFERRED GENERIC DRUG LIST
ALLERGIES & COLD AND FLU Preferred generic drugs MARCH 2013 supply* for $5 supply* for $10 and $15 * The day supply is based upon the average dispensing patterns for the specific drug and strength. 90-
More informationMVP s Medicare Stars Ratings: High Risk Medications
MVP s Medicare Stars Ratings: High Risk Medications The Center for Medicare and Medicaid Services (CMS) uses the Star Rating System to evaluate Medicare Advantage health plans as well as their networks
More informationMembers enjoy more Pharmacy savings *
Sam s Plus Members enjoy more Pharmacy savings 5 prescription drugs available for FREE Generic medications: Donepezil, Pioglitazone, Escitalopram, Finasteride and Vitamin D2 50,000IU are $ 0 for a 30-day
More informationPharmacy Savings Program
Pharmacy Savings Program SELECT GENERICS DRUG LIST The Pharmacy Savings Program provides you with savings on select generic medications included on this list. The prices for these select generic medications
More informationDisclosures Christer Allgulander
How Patients With Generalized Anxiety Disorder (GAD) Are Treated in Specialized Care: A Pharmacoepidemiological Case Register Study in Sweden Christer Allgulander MD, Karolinska Institutet, Sweden Jan
More informationHow To Write A Medication Review
Medication review for older hospialized patients Annemie Somers Ghent University Hospital, Belgium PharmD, PhD Journeé de formation CMP Studiedag MFC 25/10/13 1 Content Medication review: 1. Definition,
More informationObjectives. Scenario One. Literature Search. Background. Things That Make Your INR Go Hmmm: Pearls From An Emergency Pharmacist
Things That Make Your INR Go Hmmm: Pearls From An Emergency Pharmacist I have no potential or actual conflicts of interest to declare Dawn Dalen, BSP, ACPR, PharmD Clinical Practice Leader Pharmacy Central
More informationAdherence to oral cancer therapies
Adherence to oral cancer therapies Just take your medicine Linda Nielsen, MS, DNPc, AOCNP Hematology Oncology of Indiana, PC Importance of Adherence Study of breast cancer patients, adherence dropped from
More informationAn Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse
Drug Testing An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse Printed on August 18, 2016 1:59 pm CST 2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.
More informationNLPDP Coverage Status Table December 2015. Initial and maintenance fills are limited to a maximum 30 days
Coverage Table December 2015 02238646 282 MEP TABLET OPEN No 500 0.2103 02234510 282 TABLET OPEN No 500 0.0726 02238645 292 TABLET OPEN No 50 0.1877 02192691 3TC 10 MG/ML SOLUTION OPEN No 240 0.3454 02192683
More informationPHARMACOTHERAPY UPDATE
PHARMACOTHERAPY UPDATE Benjamin Gross, Pharm D, BCPS, BCACP, BC ADM, CDE Associate Professor Director of Residency Programs Lipscomb University College of Pharmacy and Health Sciences 1 DISCLOSURE I DO
More informationCoadministered Agent Dosage atazanavir 300 mg orally once daily
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TYBOST safely and effectively. See full prescribing information for TYBOST. TYBOST (cobicistat) tablets,
More informationPractical How-to: Treating Patients with New Anticoagulants case scenarios
Practical How-to: Treating Patients with New Anticoagulants case scenarios Robert Barcelona, PharmD, BCPS, Matthew Eisen, MD and Lindsey Federle, PharmD, BCPS Objectives Patient Case #1 o Discuss data
More information5/21/2012. JCAHO National Patient Safety Goal: Maintain and communicate accurate patient medication information.
Is 3 rd leading cause of patient harm Medical errors - 8 th leading cause of death in the US Each year in the US, est. 450,000000 preventable med-related adverse events occur 20% of patients have complications
More informationMy remarks today and the information contained in these slides do not necessarily reflect the official views of FDA.
Possible Criteria that Warrant In Vivo P-Glycoprotein Glycoprotein-Mediated Drug Interaction Studies Based on In Vitro Assessment Lei Zhang, Ph.D. Office of Clinical Pharmacology Office of Translational
More informationManaging potential drug-drug interactions to achieve success in HCV triple therapy. David Back University of Liverpool
Managing potential drug-drug interactions to achieve success in HCV triple therapy David Back University of Liverpool Understanding the metabolic pathways of DAAs Drug CYP 3A4 P-gp Telaprevir Boceprevir
More informationDrugs to consider prescribing by brand name or where brands should not be switched
Index Page Index Page Adrenaline (epinephrine) prefilled syringes 2 Hormone replacement therapy oral 3 Alprostadil injection 4 Human papillomavirus vaccine 5 Aminophylline modified release 2 Insulins 3
More informationIf your drug is not on the list just give us a call for a price. Ask us for details on how to avoid the higher deductible generic price.
If your drug is not on the list just give us a call for a price. Ask us for details on how to avoid the higher deductible generic price. FREE SHIPPING TO AL, CT, DE, FL, GA, IN, KS, MA, MO, MS, NC, NH,
More informationNovel oral anticoagulants (NOACs): novel problems and their solutions
Novel oral anticoagulants (NOACs): novel problems and their solutions Martin H. Ellis MD Hematology Institute and Blood Bank Meir Medical Center January 2013 OVERVIEW NOACs in clinical use Review of pivotal
More informationNovel Oral Anticoagulants (NOACs) Prescriber Update 2013
Novel Oral Anticoagulants (NOACs) Prescriber Update 2013 Indications/Contraindications Indications Orthopedic VTE Prophylaxis VTE Treatment Stroke Prevention for non-valvular AF Contraindications 150 mg
More informationNovel Anticoagulants: Case of Mr. T
Novel Anticoagulants: Case of Mr. T Your Orthopedic surgeon calls you from the operating room requesting advice on VTE prevention for a 45yo male with congenital hip dysplasia and a remote history of DVT,
More informationDrug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers
Home > Drugs > Development & Approval Process (Drugs) > Development Resources Drugs Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers CYP Enzymes In vitro In vivo Examples
More informationLISTING OF HERBS/INTERACTIONS
LISTING OF HERBS/INTERACTIONS Capsicum Angiotensin-converting enzyme (ACE) inhibitors used for diabetic kidney disease, heart failure, high blood pressure Theophylline (Elixophyllin, Uniphyl) an asthma
More informationNotice from the Executive Officer: Supporting Sustainability and Access for the Ontario Drug Benefit Program
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Supporting Sustainability and Access for the Ontario Drug Benefit Program Responsible management of
More information. ก ก 1. Actifed tab/syr. Triprolidine : should be stored in tight, light-resistant Pseudoepedrine : Triprolidine (p.25) Pseudoepedrine (p.
ก ก. 2553 (p.807) 3. Adrenaline inj. 1mg/ml (Epinephrine inj.) ( Druginfor. p.629) 4. Aminophylline/ Theophylline inj. (Drug infor. Ed. 11 th p.1339) 5. Amlodipine + HCTZ (Moduretic). ก ก 1. Actifed tab/syr.
More informationAETNA BETTER HEALTH Prior Authorization guidelines for Step Therapy
AETNA BETTER HEALTH Prior Authorization guidelines for Step Therapy Definition A form of automated Prior Authorization whereby one or more prerequisite medications, which may or may not be in the same
More informationProduct Catalog. 65862-0073-60 Abacavir Tablets 300 mg 60 80 80 AB Ziagen Yellow
65862-0073-60 Abacavir Tablets 300 mg 60 80 80 AB Ziagen Yellow 13107-0058-01 Acetaminophen & Codeine Tablets, C-III 300 mg / 15 mg 100 216 216 AA Tylenol-Codeine White/Off-White 13107-0059-01 Acetaminophen
More informationGuidance for prescribing of Dabigatran (Pradaxa ) Rivaroxaban (Xarelto ) and Apixaban (Eliquis ) in Patients with Non-Valvular AF
Guidance for prescribing of Dabigatran (Pradaxa ) Rivaroxaban (Xarelto ) and Apixaban (Eliquis ) in Patients with Non-Valvular AF Lesley Davey Staffordshire and Lancashire CSU November 2013 (Review November
More information8. Application Of Pharmacogenetics In Dose Individualization In Diabetes, Psychiatry, Cancer And Cardiology
8. Application Of Pharmacogenetics In Dose Individualization In Diabetes, Psychiatry, Cancer And Cardiology Dorota Tomalik-Scharte Department of Pharmacology, University of Cologne, Clinical Pharmacology
More informationJuly 2015 P & T Updates
Commercial Triple Tier 4th Tier Applicable Traditional CORLANOR 3 2 2 tablets per day GLYXAMBI 3 2 1 tablet per day Alternatives carvedilol, bisoprolol, metoprolol succinate, digoxin, hydralazine, isosorbide
More informationMedicines for Heart Disease
Medicines for Heart Disease There are many medicines to treat heart disease. Ask your doctor, nurse or pharmacist if you have questions about your medicines. Take medicines as directed. Do NOT stop taking
More informationMedicare Part D. Take Control of Your Prescription Drug Costs. Inside: information you need to enroll.
2010 Take Control of Your Prescription Drug Costs Medicare Part D Inside: information you need to enroll. IBPDP3179522_XACE000 C0009_PDP3179522_000 When you are ready to enroll: Call 1-866-804-3860, TTY
More informationTaking Over-the-Counter (OTC) Medicines Safely
Taking Over-the-Counter (OTC) Medicines Safely This chart contains information about some of the more frequent drug interactions that may occur when you are taking over-the-counter (OTC) medicines with
More informationFollow-up Medical History (FH-1)
9FH126 Jan 10 Citalopram for Agitation in Alzheimer s Disease CitAD (FH-1) Reference #: Purpose: Record the interval medical history. When: At F3, F6, and F9. Completed by: CitAD certified clinician. Instructions:
More informationDrugs with Anticholinergic Activity
PL Detail-Document #271206 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER December 2011 Drugs with Anticholinergic
More informationPractical Management of Patients receiving Rivaroxaban 울산의대 서울아산병원 심장내과 최기준
Practical Management of Patients receiving Rivaroxaban 울산의대 서울아산병원 심장내과 최기준 Contents Converting to/from rivaroxaban Measuring levels of rivaroxaban Patients potentially at higher risk of bleeding Renal
More informationMICHILD CHILDREN S SPECIAL HEALTH CARE SERVICES (CSHCS) FORMULARY Effective October 2015
MICHILD CHILDREN S SPECIAL HEALTH CARE SERVICES (CSHCS) FORMULARY Effective October 2015 Provided by EnvisionRxOptions Introduction The Total Health Care (THC) MIChild Children s Special Health Care Services
More informationKronologisk listing av trinnprisprodukter etter lanseringstidspunkt. LIS priser er gjeldende for 2011
Kronologisk listing av trinnprisprodukter etter lanseringstidspunkt. LIS priser er gjeldende for 2011 LIS AUP (SLVs kalk) Gjeldende trinnpris PRODUSENT PAKNINGSTYPE OG STYRKEGRAD ANT TABLETTER PRIS FOR
More informationRIVAROXABAN. Consumer Information
RIVAROXABAN Consumer Information Rivaroxaban is a medicine that is used to increase the time it takes for blood to clot. It belongs to a class of medicines called anticoagulants, which are sometimes also
More informationDrug-Drug Interactions with Antiretroviral Therapy. Case-Based Discussions
Drug-Drug Interactions with Antiretroviral Therapy Case-Based Discussions Alice K. Pau, Pharm.D. Staff Scientist (Clinical) Clinical Pharmacy Specialist DCR/NIAID/NIH Learning Objectives Upon completion
More informationManaging HIV Patients with Cardiac Disease: How to Avoid Going Into Heart Failure (the clinician, not the patient)
Managing HIV Patients with Cardiac Disease: How to Avoid Going Into Heart Failure (the clinician, not the patient) Alice Tseng, Pharm.D., FCSHP, AAHIVP April 25, 2015 Higher Prevalence of Age-Related
More informationCICLOSPORIN. What are the aims of this leaflet?
CICLOSPORIN What are the aims of this leaflet? This leaflet has been written to help you understand more about ciclosporin. It tells you what it is, how it works, how it is used to treat skin conditions,
More informationTRENDS IN ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES IN MELBOURNE 2009 10
AMBO PROJECT: ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES TRENDS IN ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES IN MELBOURNE 2009 10 Belinda Lloyd ambo project: Alcohol and Drug Related Ambulance
More informationPATIENT INFORMATION LEAFLET. Sinthrome Tablets 1mg acenocoumarol
PATIENT INFORMATION LEAFLET Sinthrome Tablets 1mg acenocoumarol Read all of this leaflet carefully before you start taking this medicine because it contains important information for you Keep this leaflet.
More informationCytochrome P450 s! Toxicity and Detoxification! Bioquímica! Dr. Braulio Jiménez-Vélez!
Cytochrome P450 s! Toxicity and Detoxification! Bioquímica! Dr. Braulio Jiménez-Vélez! Cytochrome P450! Cytochrome P450! Cytochrome P450! Medicamentos! Toxicidad! Cytochrome P450! Cytochrome P450! Cytochrome
More informationTSOAC Initiation Checklist
Task Establish appropriate dose based on anticoagulant selected, indication and patient factors such as renal function. Evaluate for medication interactions that may necessitate TSOAC dose adjustment.
More informationRivaroxaban Mohamed El Setiha, MD. Prof of Cardiology Tanta University Antithrombotics That Have Changed Clinical Practice Anticoagulants Low-molecular-weight l heparin Antiplatelet Drugs Thienopyridines
More informationfor Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor
Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION A Notice of Compliance with Conditions (NOC/c) is a type of approval to sell a drug in Canada. Pr ZYKADIA TM is used
More informationDrug interactions involving warfarin: Practice tool and practical management tips
P R A C T I C E T O O L P E E R - R E V I E W E D interactions involving warfarin: Practice tool and practical management tips Tammy J. Bungard, BSP, PharmD; Erin Yakiwchuk, BSP, ACPR; Michelle Foisy,
More informationExcerpt from Food-Medication Interactions 13th edition by Zaneta M. Pronsky, MS, RD, LDN, FADA INTRODUCTION
Excerpt from Food-Medication Interactions 13th edition by Zaneta M. Pronsky, MS, RD, LDN, FADA INTRODUCTION The study of the absorption, distribution, metabolism and excretion of drugs is referred to as
More informationHIV Drug Interactions
Approach to Drug Interactions HIV Drug Interactions Joshua R. Sawyer, PharmD, AAHIV-P Clinical Assistant Professor, Pharmacy Practice School of Pharmacy and Pharmaceutical Sciences University at Buffalo
More informationHealth Plan & Formulary A Simple Resource to Help You Understand Your Benefits. Comparison Guide
Health Plan & Formulary A Simple Resource to Help You Understand Your Benefits Comparison Guide Contents What Does Rx Formulary Mean?... 3 How To Use This Comparison Guide... 3 A Note To Members... 3 Health
More informationSPORANOX (itraconazole) Oral Solution BOXED WARNINGS
SPORANOX (itraconazole) Oral Solution BOXED WARNINGS Congestive Heart Failure, Cardiac Effects and Drug Interactions: When itraconazole was administered intravenously to dogs and healthy human volunteers,
More informationPharmacological Management of Dementia
Pharmacological Management of Dementia Christopher Sullivan Lead Clinical Pharmacist South and West Devon Devon Partnership Trust Overview Management of cognitive symptoms Management of non-cognitive symptoms
More information